NCT06729216

Brief Summary

The aim of the study is to compare the efficiency of broth microdilution versus disk diffusion method for antifungal drug susceptibility testing of the most used drugs in dermatophytosis treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

December 8, 2024

Last Update Submit

May 10, 2025

Conditions

Dermatophyte Infection

Outcome Measures

Primary Outcomes (1)

  • Precent susceptibility to each drug

    Measure the area of inhibition zone of the drugs to the fungus on the culture

    3 months

Study Arms (1)

Antifungal susceptibility testing (AFST)

Diagnostic Test: Antifungal susceptibility testing (AFST)

Interventions

Antifungal susceptibility testing (AFST)DIAGNOSTIC_TEST

testing the fungal susceptibility to different drugs

Antifungal susceptibility testing (AFST)

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with dermatophytic skin infection

You may qualify if:

  • Patients diagnosed clinically with dermatophytosis, any age group and any sex

You may not qualify if:

  • Patients under either Local or systemic antifungal treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dermatomycoses

Condition Hierarchy (Ancestors)

MycosesBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University doctor

Study Record Dates

First Submitted

December 8, 2024

First Posted

December 11, 2024

Study Start

June 1, 2025

Primary Completion

July 1, 2025

Study Completion

August 1, 2025

Last Updated

May 14, 2025

Record last verified: 2025-05